BRECADD IS NON‐INFERIOR TO EBEACOPP IN PATIENTS WITH ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA: EFFICACY RESULTS OF THE GHSG PHASE III HD21 TRIAL
P. Borchmann,A. A. Moccia,R. Greil, G. Schneider,M. Hertzberg,V. Schaub,A. Hüttmann,F. Keil,J. Dierlamm,M. Hänel,U. Novak,J. Meissner,A. Zimmermann,S. Mathas,J. M. Zijlstra,A. Fosså,A. Viardot,B. Hertenstein,S. Martin,P. Giri,P. Kamper,D. Molin,S. Kreissl,J. Ferdinandus,M. Fuchs,A. Rosenwald,W. Klapper,H. Eich,C. Baues,M. Hallek,M. Dietlein,C. Kobe,V. Diehl,A. Engert Hematological Oncology（2023）
AI 理解论文
溯源树
样例
